Cargando…

Gsk3 Signalling and Redox Status in Bipolar Disorder: Evidence from Lithium Efficacy

Objective. To discuss the link between glycogen synthase kinase-3 (GSK3) and the main biological alterations demonstrated in bipolar disorder (BD), with special attention to the redox status and the evidence supporting the efficacy of lithium (a GSK3 inhibitor) in the treatment of BD. Methods. A lit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luca, Antonina, Calandra, Carmela, Luca, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007367/ https://www.ncbi.nlm.nih.gov/pubmed/27630757 http://dx.doi.org/10.1155/2016/3030547

Ejemplares similares

Sleep disorders and depression: brief review of the literature, case report, and nonpharmacologic interventions for depression
por: Luca, Antonina, et al.
Publicado: (2013)

GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder
por: Valvezan, Alexander J., et al.
Publicado: (2012)

Haloperidol augmentation of fluvoxamine in skin picking disorder: a case report
por: Luca, Maria, et al.
Publicado: (2012)

Haplotype Analysis of GSK-3β Gene Polymorphisms in Bipolar Disorder Lithium Responders and Nonresponders
por: Iwahashi, Kazuhiko, et al.
Publicado: (2014)

Autonomic nervous system and lipid metabolism: findings in anxious-depressive spectrum and eating disorders
por: Pistorio, Elisabetta, et al.
Publicado: (2011)

Accelerated Aging in Major Depression: The Role of Nitro-Oxidative Stress
por: Luca, Maria, et al.
Publicado: (2013)

Psychomotor retardation and externally oriented thinking in major depression
por: Luca, Maria, et al.
Publicado: (2013)

The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia
por: Luca, Maria, et al.
Publicado: (2015)

Molecular Bases of Alzheimer’s Disease and Neurodegeneration: The Role of Neuroglia
por: Luca, Antonina, et al.
Publicado: (2018)

EFFICACY OF LITHIUM PROPHYLAXIS IN BIPOLAR AFFECTIVE DISORDER
por: Mathew, Manu R.K., et al.
Publicado: (1995)

Epidemiology and treatment of mood disorders in a day hospital setting from 1996 to 2007: an Italian study
por: Luca, Maria, et al.
Publicado: (2013)

Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic Implications
por: Muneer, Ather
Publicado: (2017)

Lithium and Therapeutic Targeting of GSK-3
por: Snitow, Melinda E., et al.
Publicado: (2021)

Prevalence of depression and its relationship with work characteristics in a sample of public workers
por: Luca, Maria, et al.
Publicado: (2014)

Nothing to smile about
por: Luca, Maria, et al.
Publicado: (2014)

Inhibition of GSK3 by lithium, from single molecules to signaling networks
por: Freland, Laure, et al.
Publicado: (2012)

Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder
por: Campbell, Iain H., et al.
Publicado: (2022)

Pharmacogenomics of Lithium Response in Bipolar Disorder
por: Vecera, Courtney M., et al.
Publicado: (2021)

Clinical features and imaging findings in a case of Capgras syndrome
por: Luca, Maria, et al.
Publicado: (2013)

Psychopathological Variables and Sleep Quality in Psoriatic Patients
por: Luca, Maria, et al.
Publicado: (2016)

Lithium promotes neural precursor cell proliferation: evidence for the involvement of the non-canonical GSK-3β-NF-AT signaling
por: Qu, Zhaoxia, et al.
Publicado: (2011)

More robust evidence for the efficacy of lithium in the long-term treatment of bipolar disorder: should lithium (again) be recommended as the single preferred first-line treatment?
por: Nolen, Willem A
Publicado: (2015)

SUBSYNDROMAL SYMPTOMS IN BIPOLAR DISORDER : ROLE OF LITHIUM
por: Andrade, Chittaranjan, et al.
Publicado: (2003)

Lithium: a key to the genetics of bipolar disorder
por: Cruceanu, Cristiana, et al.
Publicado: (2009)

A safe lithium mimetic for bipolar disorder
por: Singh, Nisha, et al.
Publicado: (2013)

LITHIUM IN THE TREATMENT OF BIPOLAR DISORDER: PHARMACOLOGY AND PHARMACOGENETICS
por: Alda, Martin
Publicado: (2015)

Lithium Treatment Over the Lifespan in Bipolar Disorders
por: Volkmann, Constantin, et al.
Publicado: (2020)

Immunophenotypes associated with bipolar disorder and lithium treatment
por: Wu, Tai-Na, et al.
Publicado: (2019)

Lithium Pharmacokinetics in the Perinatal Patient With Bipolar Disorder
por: Clark, Crystal T., et al.
Publicado: (2022)

Lithium and Valproic Acid in Bipolar Disorders and Beyond
por: Scarselli, Marco
Publicado: (2023)

Lithium management in pregnant patients with bipolar disorder
por: Romero Gerechter, I., et al.
Publicado: (2023)

The association of glycogen synthase kinase-3beta (GSK-3β) gene polymorphism with kidney function in long-term lithium-treated bipolar patients
por: Rybakowski, Janusz K, et al.
Publicado: (2013)

Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors
por: Crapanzano, Calogero, et al.
Publicado: (2022)

Comment to the Letter to the Editor entitled “Lithium in drinking water and suicide risk” by Tomoyuki Kawada
por: Luca, Antonina, et al.
Publicado: (2022)

Bipolar disorder: A brief examination of lithium therapy
por: Farinde, Abimbola
Publicado: (2013)

Brain oscillations in bipolar disorder and lithium-induced changes
por: Atagün, Murat İlhan
Publicado: (2016)

Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder
por: Lundberg, Martin, et al.
Publicado: (2020)

Advances in Therapeutic Monitoring of Lithium in the Management of Bipolar Disorder
por: Sheikh, Mahsa, et al.
Publicado: (2022)

Regional lithium prescription rates and recurrence in bipolar disorder
por: Sköld, Martin, et al.
Publicado: (2021)

Clinical correlates of lithium response in patients with bipolar disorder on long-term lithium therapy
por: Mahal, Pankaj, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7jnal4jkceln166ga82psiveat